Your browser doesn't support javascript.
loading
Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment.
Jian, Yuan; Chang, Long; Shi, Ming-Xia; Sun, Ying; Chu, Xiao-Xia; Xue, Hua; Huang, Wen-Rong; Shen, Xu-Liang; Ma, Jie; Jia, Guo-Rong; Feng, Ya-Qing; Xi, Zhen-Fang; Zhao, Yan-Hong; Ma, Yan-Ping; Xiao, Jing; Ma, Guang-Yu; Wang, Qing-Ming; Bao, Li; Dong, Yu-Jun; Zhou, He-Bing; Sun, Chun-Yan; Su, Guo-Hong; Yan, Yan; Qimuge, Sai-Yin; Su, Li-Ping; Sun, Jing-Nan; Tian, Wei-Wei; Sun, Xiu-Li; Ing, Hong-Mei; Gao, Da; Chen, Wen-Ming; Li, Jian; Gao, Wen.
Afiliação
  • Jian Y; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Chang L; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Shi MX; Department of Hematology, The First Affiliated Hospital of Kunming Medical University, Hematology Research Center of Yunnan Province, Kunming, China.
  • Sun Y; Department of Hematology, Chifeng Municipal Hospital, Chifeng, China.
  • Chu XX; Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Qingdao, China.
  • Xue H; Department of Hematology, Affiliated Hospital of Hebei University, Baoding, China.
  • Huang WR; Department of Hematology, The Fifth Medical Center of People's Liberation Army General Hospital, Beijing, China.
  • Shen XL; Department of Hematology, Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China.
  • Ma J; Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Jia GR; Department of Hematology, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China.
  • Feng YQ; Department of Hematology, The Third People's Hospital Of Datong, Datong, China.
  • Xi ZF; Department of Hematology, Linfen People's Hospital, Linfen, China.
  • Zhao YH; Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Ma YP; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Xiao J; Department of Hematology, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China.
  • Ma GY; Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Wang QM; Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Bao L; Department of Hematology, Beijing Jishuitan Hospital, Beijing, China.
  • Dong YJ; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Zhou HB; Department of Hematology, Beijing Luhe Hospital, Capital Medical University, Beijing, China.
  • Sun CY; Institution of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Su GH; The Second Department of Hematology, Cangzhou Central Hospital, Cangzhou, China.
  • Yan Y; Department of Hematology, Bayannur Hospital, Bayannur, China.
  • Qimuge SY; Department of Hematology, Ordos Central Hospital, Ordos, China.
  • Su LP; Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China.
  • Sun JN; Department of Oncology, The First Hospital of Jilin University, Changchun, China.
  • Tian WW; Department of Oncology, The First Hospital of Jilin University, Changchun, China.
  • Sun XL; Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Ing HM; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Gao D; Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
  • Chen WM; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Gao W; Department of Hematology, Myeloma Research Center of Beijing, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Blood Adv ; 7(24): 7581-7584, 2023 12 26.
Article em En | MEDLINE | ID: mdl-37922425
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article